A Mouse Fibroblast Cell Model to Study Human Papillomavirus-Associated Tumorigenesis

By Hernández P.   Merino N.   Lopez-Ocejo O.   Araña M.J.  

Biochemical and Biophysical Research Communications, Vol. 270, Iss. 1, 2000-04 ,pp. : 119-124

Elsevier

Access to resources Recommend Favorite

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

By Hung Chien-Fu   Ma Barbara   Monie Archana   Tsen Shaw-Wei   Wu T-C  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 4, 2008-04 ,pp. : 421-439

Informa Healthcare

Access to resources Recommend Favorite

Replication-Associated Activities of Purified Human Papillomavirus Type 11 E1 Helicase

By Rocque W.J.   Porter D.J.T.   Barnes J.A.   Dixon E.P.   Lobe D.C.   Su J-L.   Willard D.H.   Gaillard R.   Condreay J.P.   Clay W.C.   Hoffman C.R.   Overton L.K.   Pahel G.   Kost T.A.   Phelps W.C.  

Protein Expression and Purification, Vol. 18, Iss. 2, 2000-03 ,pp. : 148-159

Academic Press

Access to resources Recommend Favorite

Human papillomavirus vaccine: progress and the future

By Dinh Tri A   Benoit Michelle F  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 479-485

Informa Healthcare

Access to resources Recommend Favorite

Cervarix™ – a bivalent L1 virus-like particle vaccine for prevention of human papillomavirus type 16- and 18-associated cervical cancer

By Crosbie Emma J   Kitchener Henry C  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 3, 2007-03 ,pp. : 391-396

Informa Healthcare

Access to resources Recommend Favorite